Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Satellos Bioscience Inc. (T.MSL) had Income from Continuous Operations of 0.95M for the most recently reported fiscal year, ending 2017-12-31.
| Income Statement Financials | |
-- |
|
0.95M |
|
-- |
|
-- |
|
-- |
|
-1.13M |
|
-- |
|
0.95M |
|
0.95M |
|
0.95M |
|
|
Income from Continuous Operations |
0.95M |
0.95M |
|
0.95M |
|
-1.13M |
|
-1.12M |
|
4.22M |
|
4.22M |
|
-0.15 |
|
-0.15 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
1.06M |
|
-- |
|
-- |
|
-- |
|
0.22M |
|
0.84M |
|
0.84M |
|
0.84M |
|
4.22M |
|
| Cash Flow Statement Financials | |
-0.94M |
|
-- |
|
-- |
|
1.82M |
|
0.87M |
|
-0.95M |
|
0.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.77 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-0.94M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
113.80% |
|
113.80% |
|
89.95% |
|
113.80% |
|
0.26 |
|
-0.22 |
|
-0.22 |
|